Barney Han - Profile and Investment Details

Investor Profile

Barney Han is a Venture Capital, Private Equity Firm based in with a diverse investment portfolio that includes companies such as Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics, Atea Pharmaceuticals, Imperative Care, Nuvation Bio, Mavrik Dental Systems, Alzheon, UNUM Therapeutics, Pulmonx, Hua Medicine, Tunitas Therapeutics, Duoning BiotechCyteir Therapeutics, Conventus Orthopaedics, Sagimet Biosciences, GenFleet Therapeutics, Quantum Surgical, Rapid Micro Biosystems, Mainstay Medical, I-Mab Biopharma, Grail, Synlogic, Jinxin Fertility, IsoPlexis, Venclose, ImmunGene, TESARO, Chinook Therapeutics, Sorrento Therapeutics, RefleXion Medical, Wacai.com, Shockwave Medical, Otonomy, Akeso Biopharma, LinkDoc Technology, CG Oncology, . Over time, Barney Han has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Barney Han is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Investment Management, Life Science, Biotechnology, Genomics, FinTech, Digital Health, Medical, Therapeutics, Media and Entertainment, Personal Health, Emergency Medicine, Pharmaceuticals may find it worthwhile to explore potential connections with Barney Han, as their portfolio suggests a familiarity and interest in this area.

Understanding Barney Han’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.